Reliant Pharmaceuticals, Inc. Pulls IPO Due To Conditions

November 17, 2005 |

1 min read

WASHINGTON, Nov 17 (Reuters) - Reliant Pharmaceuticals Inc., which markets branded cardiovascular pharmaceutical products, on Thursday withdrew its planned $300 million initial public offering due to unfavorable market conditions.

IPO

MORE ON THIS TOPIC

Contemporary digital collage art. Modern trippy design. Hands holding fork and spoon

Earnings

Gilead Still Hungry for Deals as HIV Portfolio Grows, Veklury Crashes

October 31, 2025

·

2 min read

·

Tristan Manalac

Concept art showing a money icon and human hands

IPO

Evommune Joins IPO Class With Planned $160M Raise for Immuno Pipeline

October 31, 2025

·

2 min read

·

Tristan Manalac

Vector illustration of two businessmen engaged in a hand wrestling match, symbolizing competition, rivalry, power struggles, competitive environments, and conflict resolution concepts

Mergers & acquisitions

UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer

October 30, 2025

·

4 min read

·

Annalee Armstrong

A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.

Earnings

Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem

October 28, 2025

·

3 min read

·

Annalee Armstrong